Live stream of Novartis sponsored Satellite Symposium
©2018 Novartis Pharma AG, CH-4002 Basel –
April 2018 - GLCM/HTF/0556


Novartis sponsored Satellite Symposium at Heart Failure 2018 Congress
Resolving dilemmas in the treatment of heart failure
Vienna, Austria
Faculty: John McMurray (co-chair and presenter), Frank Ruschitzka (co-chair & moderator); Michele Senni (presenter), Richard Hobbs (presenter)
Topic | Faculty | |
---|---|---|
12:45–12:50 | Welcome and introduction | Frank Ruschitzka (Switzerland) |
12:50–13:05 | The dilemma of treating perceived stable heart failure patients | John McMurray (UK) |
13:05–13:20 | The dilemma of treating patients following hospitalization for acute heart failure decompensation | Michele Senni (Italy) |
13:20–13:35 | The dilemma of ensuring continuity of optimal care for heart failure patients | Richard Hobbs (UK) |
13:35–13:55 | Panel discussion and audience Q & A |
Moderator: Frank Ruschitzka (Switzerland) |
13:55–14:00 | Summary and close | John McMurray (UK) |
After this session, it is expected that participants will be able to:
- Navigate the challenges in clinical decisions for patients perceived as having stable heart failure in light of current evidence and available disease modifying therapies
- Recognize the high risk of recurrent events and deterioration after hospitalization for acute heart failure decompensation and understand options to optimize treatment before discharge
- Appreciate the importance of well-coordinated transition of care between the cardiology/hospital-setting and primary care for continued optimal treatment of heart failure patients
©2018 Novartis Pharma AG, CH-4002 Basel – April 2018 - GLCM/HTF/0556

Your questions on dilemmas in the treatment of heart failure answered
Faculty: Frank Ruschitzka (moderator), John McMurray (panelist), Carolyn Lam (panelist)
This Satellite Symposium – Experts on the Spot session titled ‘Your questions on dilemmas in the treatment of heart failure answered’ was moderated by Frank Ruschitzka. This session provided delegates the opportunity to ask questions to the expert faculty panelists; John McMurray and Carolyn Lam, following the Novartis sponsored Satellite Symposium at Heart Failure 2018, on acute and chronic heart failure. Watch this video recording to hear the questions and discussions from this interactive 30 minute session.
It is expected that after this session, participants will be able to:
- Navigate the challenges in clinical decisions for patients perceived as having stable heart failure in light of current evidence and available disease modifying therapies.
- Recognize the high risk of recurrent events and deterioration after hospitalization for acute heart failure decompensation and understand options to optimize treatment before discharge.
- Appreciate the importance of well-coordinated transition of care between the cardiology/hospital-setting and primary care for continued optimal treatment of heart failure patients.
©2018 Novartis Pharma AG, CH-4002 Basel – April 2018 - GLCM/HTF/0556
